Lyrica
- Product NDC
- 52959-891
- 11-digit product format
- 529590891
- Labeler code
- 52959
- Product ID
- 52959-891_4c9b2c15-78b0-42b1-a146-026282c33076
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PREGABALIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- H.J. Harkins Company, Inc.
- Application
- NDA021724
- Marketing category
- NDA
- Marketing start
- 2004-12-30
- Marketing end
- 0000-00-00
- Substance
- PREGABALIN
- Active strength
- 50 mg/1
- DEA schedule
- CV
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
Source provenance: Browse the complete Orange Book source catalog.
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 52959-891-02 | 2019-11-13 | C162847 | 48780-1 | 97449f38-bd20-f6ea-e053-dbdaa90aa703 | These highlights do not include all the information needed to use LYRICA safely and effectively. See full prescribing information for LYRICA. LYRICA (pregabalin) Capsules, CV LYRICA (pregabalin) Oral Solution, CV Initial U.S. Approval: 2004 |
| 52959-891-30 | 2019-11-13 | C162847 | 48780-1 | 97449f38-bd20-f6ea-e053-dbdaa90aa703 | These highlights do not include all the information needed to use LYRICA safely and effectively. See full prescribing information for LYRICA. LYRICA (pregabalin) Capsules, CV LYRICA (pregabalin) Oral Solution, CV Initial U.S. Approval: 2004 |
| 52959-891-60 | 2019-11-13 | C162847 | 48780-1 | 97449f38-bd20-f6ea-e053-dbdaa90aa703 | These highlights do not include all the information needed to use LYRICA safely and effectively. See full prescribing information for LYRICA. LYRICA (pregabalin) Capsules, CV LYRICA (pregabalin) Oral Solution, CV Initial U.S. Approval: 2004 |
| 52959-891-90 | 2019-11-13 | C162847 | 48780-1 | 97449f38-bd20-f6ea-e053-dbdaa90aa703 | These highlights do not include all the information needed to use LYRICA safely and effectively. See full prescribing information for LYRICA. LYRICA (pregabalin) Capsules, CV LYRICA (pregabalin) Oral Solution, CV Initial U.S. Approval: 2004 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 52959-891-02 | Lyrica | 120 in 1 BOTTLE | CAPSULE | 120 | | 4 |
| 52959-891-30 | Lyrica | 30 in 1 BLISTER PACK | CAPSULE | 30 | | 4 |
| 52959-891-60 | Lyrica | 60 in 1 BOTTLE | CAPSULE | 60 | | 4 |
| 52959-891-90 | Lyrica | 90 in 1 BOTTLE | CAPSULE | 90 | | 4 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| PREGABALIN | ACTIVE INGREDIENT | 55JG375S6M | LYRICA (PREGABALIN) CAPSULE [H.J. HARKINS COMPANY, INC.] | 4 | |
| PREGABALIN | ACTIVE MOIETY | 55JG375S6M | LYRICA (PREGABALIN) CAPSULE [H.J. HARKINS COMPANY, INC.] | 4 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | LYRICA (PREGABALIN) CAPSULE [H.J. HARKINS COMPANY, INC.] | 4 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | LYRICA (PREGABALIN) CAPSULE [H.J. HARKINS COMPANY, INC.] | 4 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | LYRICA (PREGABALIN) CAPSULE [H.J. HARKINS COMPANY, INC.] | 4 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | LYRICA (PREGABALIN) CAPSULE [H.J. HARKINS COMPANY, INC.] | 4 | |
| POTASSIUM HYDROXIDE | INACTIVE INGREDIENT | WZH3C48M4T | LYRICA (PREGABALIN) CAPSULE [H.J. HARKINS COMPANY, INC.] | 4 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | LYRICA (PREGABALIN) CAPSULE [H.J. HARKINS COMPANY, INC.] | 4 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | LYRICA (PREGABALIN) CAPSULE [H.J. HARKINS COMPANY, INC.] | 4 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | LYRICA (PREGABALIN) CAPSULE [H.J. HARKINS COMPANY, INC.] | 4 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | LYRICA (PREGABALIN) CAPSULE [H.J. HARKINS COMPANY, INC.] | 4 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | LYRICA (PREGABALIN) CAPSULE [H.J. HARKINS COMPANY, INC.] | 4 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | LYRICA (PREGABALIN) CAPSULE [H.J. HARKINS COMPANY, INC.] | 4 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | LYRICA (PREGABALIN) CAPSULE [H.J. HARKINS COMPANY, INC.] | 4 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 52959-891 | LYRICA (PREGABALIN) CAPSULE [H.J. HARKINS COMPANY, INC.] | 4 | Legacy NDC, 4 package rows | 20111019_a262d7c6-2aa9-433c-b801-d8b2dcd68a0f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 52959-891-02 | 52959089102 | 120 in 1 BOTTLE | Historical |
| 52959-891-30 | 52959089130 | 30 in 1 BLISTER PACK | Historical |
| 52959-891-60 | 52959089160 | 60 in 1 BOTTLE | Historical |
| 52959-891-90 | 52959089190 | 90 in 1 BOTTLE | Historical |